Lincosamid-Antibiotika und Ihre Verwendung
Anmelder: President And Fellows Of Harvard College 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4741399
- Anmeldetag
- 10. August 2018
- Veröffentlichung
- 13. Mai 2026
- Rechtsraum
- EP
- IPC
- (VICURON PHARM INC et al.)(GLAXO GROUP LTD et al.)
Abstract
Provided are lincosamide compounds for the treatment of infectious diseases. The lincosamides described herein are modified at the amino acid (southern) region. The lincosamides may have further modification at the C-1 and C-7 positions of the aminooctose (northern) region, thus distinguishing them from lincomycin and clindamycin. Also provided are methods for preparing the lincosamide compounds, pharmaceutical compositions comprising the lincosamide compounds, and methods of treating infectious diseases using the disclosed lincosamide compounds.
Anmelder
- Firma
- President And Fellows Of Harvard College
- Land
- 🇺🇸 USA
US-amerikanische Elite-Universität mit Sitz in Cambridge, Massachusetts. Harvard betreibt Forschung und Patentierung in zahlreichen Feldern, insbesondere Biotechnologie, Medizin, Life Sciences und Materialwissenschaften.
455 Patente in unserer Datenbank
Vertreten von
-
Mewburn Ellis LLP
Mewburn Ellis LLP · München